Compare Enphase Energy Inc (ENPH) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enphase Energy Inc vs Hinge Health Inc. Class A Common Stock — how do they compare? Enphase Energy Inc trades at $28.78 (market cap $4.23B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 2× Enphase Energy Inc's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Enphase Energy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| ENPH | HNGE | |
|---|---|---|
Market Cap | $4.23B | $8.48B |
Volume | 4,755,897 | 879,799 |
Sector | Energy | Health |
52-Week High | $72.33 | $105.14 |
52-Week Low | $26.12 | $31.17 |
Typical Hold Time | 72 Days | 0 Days |
Enterprise Value | $3.88B | $8.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $29.35, down 6.8% in the last session, reflecting recent volatility amid broader solar sector pressures. The stock shows a bearish technical signal with key support at $29. Valuation ratios like a P/E of 31.71 and P/S of 3.22 suggest a premium, while recent quarters saw mixed earnings with two misses. Positive developments include utility approvals for its IQ Meter Collar and advancements in solid-state transformer technology for AI data centers.
The outlook is cautious; while analyst consensus targets $43.18 implying upside, high borrowing costs and competitive risks weigh on solar stocks. Revenue declined from 2023's $2.3B to $1.47B in 2025, though net margins improved. Investors should balance growth potential in energy tech against execution risks and market sentiment shifts.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
